Contemporary Fixed-Duration Treatment Options in the First-Line Setting of Chronic Lymphocytic Leukemia: Perspectives from a Publicly Funded Healthcare System.

Simple Summary: Contemporary drug combinations are or will soon be available for the first-line treatment of chronic lymphocytic leukemia that are provided to patients within a fixed duration. Hematologists from across Canada met to discuss the attributes of these options and share considerations fo...

Full description

Bibliographic Details

Published in:	Current Oncology Vol. 32; no. 10; pp. 543 - 557
Main Authors:	Lemieux, Christopher, Phua, Chai W., Robinson, K. Sue, Owen, Carolyn, Banerji, Versha
Format:	Journal Article
Published:	MDPI Oct2025
Online Access:	View this record in EBSCOhost